Trials / Conditions / Papillary Renal Cell Carcinoma Type 2
Papillary Renal Cell Carcinoma Type 2
3 registered clinical trials studyying Papillary Renal Cell Carcinoma Type 2 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC NCT05096390 | Centre Leon Berard | Phase 2 |
| Completed | ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) NCT03685448 | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Phase 2 |
| Unknown | Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Meta NCT03177239 | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Phase 2 |